(Q44387256)

English

Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease? (English)

1 reference

Europe PubMed Central

2 December 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

author name string

Grootendorst DC

1

1 reference

Europe PubMed Central

2 December 2017

Gauw SA

2

1 reference

Europe PubMed Central

2 December 2017

Baan R

3

1 reference

Europe PubMed Central

2 December 2017

Kelly J

4

1 reference

Europe PubMed Central

2 December 2017

Murdoch RD

5

1 reference

Europe PubMed Central

2 December 2017

Sterk PJ

6

1 reference

Europe PubMed Central

2 December 2017

Rabe KF

7

1 reference

Europe PubMed Central

2 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

2 December 2017

Pulmonary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

2 December 2017

16

1 reference

Europe PubMed Central

2 December 2017

115-120

1 reference

Europe PubMed Central

2 December 2017

2

1 reference

Europe PubMed Central

2 December 2017

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the mixed phosphodiesterase III/IV inhibitor, zardaverine, on airway function in patients with chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Theophylline and Salbutamol Improve Pulmonary Function in Patients with Irreversible Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The beta-adrenoceptor

1 reference

https://api.crossref.org/works/10.1016%2FS1094-5539%2802%2900172-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1094-5539(02)00172-4

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44387256&oldid=1415272747"